Sarah Ellson co-leads the Fieldfisher LLP’s regulatory group and specialises in healthcare regulation. She acts for numerous regulators, many of which cover disciplines at the frontiers of medical science such as the Human Fertilisation and Embryology Authority, for whom Sarah has advised on new mitochondrial donation regulation and licensing and the authorisation of gene editing in research. With the Human Tissue Authority Sarah has advised on aspects of living and post mortem organ donation and DNA preservation. She has worked with health and social care regulators including the General Medical Council, Nursing and Midwifery Council, General Dental Council, the Northern Ireland and Scottish Social Care Councils, General Pharmaceutical Council, as well as those educating healthcare students. She has worked for numerous and diverse private providers in the pharmaceutical, optical, pharmacy and blood-banking sectors and increasingly supports new healthcare provider clients looking to enter the English market.
The Healthcare Law Review - 4th Edition
It is impossible to introduce a global healthcare text in 2020 without reference to the covid-19 pandemic and first and foremost to pay tribute to the commitment shown by all working in the sector: the healthcare professionals, the organisational leaders, all staff working in health and social care environments, and the scientists and public health officials seeking to navigate nations through this crisis. This review provides an introduction to healthcare economies and their legal frameworks in 15 jurisdictions, with new contributions from Cambodia, Malta and Vietnam in this edition.
In this book:
- England & Wales
- Saudi Arabia
- South Korea
- United Arab Emirates
- United States
We Also Recommend
The Pharmaceutical Intellectual Property and Competition Law Review - Edition 1